Document is current

Article History

Received: 5 September 2024

Accepted: 21 November 2024

First Online: 14 February 2025

Declarations

:

: All data collection followed HIPAA and insurance industry standards.

: Not applicable.

: EL has contracts with Savara Inc., Takeda, Grifols and the NIH for clinical trial research (payment to institution) and has received consulting fees from Partner Therapeutics and Guidepoint Global LLC. AA has a contract with Savara Inc. for clinical trial research (payment to institution), has received consulting fees from Savara Inc. and Partner Therapeutics, and served on the medical and scientific advisory board (unpaid) for the PAP Foundation. CM has research grants from Health Research Board Ireland, Enterprise Ireland and the LAM Foundation, has received consulting fees from Savara Inc., AI Therapeutics, and Theravance Inc, and has received travel support from Boehringer Ingelheim. EG has no competing interests to disclose. JC is an employee of Real Chemistry, which received funding from Savara Inc. to collect data and support manuscript development. AK is an employee of Real Chemistry, which received funding from Savara Inc. to collect data and support manuscript development. BR is an employee of Savara Inc., the study sponsor. TW has a contract with Savara Inc. for clinical trial research (payment to institution), has received consulting fees from Savara Inc. and Partner Therapeutics, served on the medical and scientific advisory board (unpaid) for the PAP Foundation, serves on the board of directors (unpaid) for the American Thoracic Society, and received financial support for travel to meetings from the PAP Foundation.